Cargando…

Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: An observational study

OBJECTIVES: Methotrexate (MTX) is the most commonly used cost-effective disease-modifying antirheumatoid drug (DMARD). Its main dose-limiting adverse effects are hepatic and hematopoietic. This cross-sectional, observational study evaluated the prevalence of hepatic and hematological adverse effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dubey, Lily, Chatterjee, Suparna, Ghosh, Alakendu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051257/ https://www.ncbi.nlm.nih.gov/pubmed/27721549 http://dx.doi.org/10.4103/0253-7613.190761

Ejemplares similares

Managing rheumatoid arthritis during COVID-19
por: Roongta, Rashmi, et al.
Publicado: (2020)

Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration
por: Guin, Aharna, et al.
Publicado: (2019)

Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis
por: Isozaki, Takeo, et al.
Publicado: (2010)

Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis
por: Salem, Heba F., et al.
Publicado: (2022)

Risk of higher dose methotrexate for renal impairment in patients with rheumatoid arthritis
por: Hayashi, Keigo, et al.
Publicado: (2020)

The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
por: Chen, Fangfang, et al.
Publicado: (2023)

Association of Angiogenic and Inflammatory Markers with Power Doppler Ultrasound Vascularity Grade and DAS28-CRP in Early Rheumatoid Arthritis: A Comparative Analysis
por: Misra, Sanchaita, et al.
Publicado: (2018)

Primary Hepatic Lymphoma in a Patient with Rheumatoid Arthritis Treated with Methotrexate
por: Tatsumi, Goichi, et al.
Publicado: (2014)

Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study
por: Lindström, Ulf, et al.
Publicado: (2023)

Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
por: Rexhepi, Sylejman, et al.
Publicado: (2012)

Methotrexate Hepatotoxicity in Patients with Rheumatoid Arthritis
por: Sotoudehmanesh, R, et al.
Publicado: (2010)

Adherence to Methotrexate therapy in Rheumatoid Arthritis
por: Arshad, Nasim, et al.
Publicado: (2016)

Evaluation of levels of oxidative stress as a potential biomarker in patients with rheumatoid arthritis
por: Mukhopadhyay, Kaushik, et al.
Publicado: (2021)

Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis
por: Patanè, Marinella, et al.
Publicado: (2013)

Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by background methotrexate dose group
por: Fleischmann, R, et al.
Publicado: (2016)

Correction to: The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis
por: Chen, Fangfang, et al.
Publicado: (2023)

Prevalence of methotrexate intolerance in rheumatoid arthritis and psoriatic arthritis
por: Bulatović Ćalasan, Maja, et al.
Publicado: (2013)

Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy
por: Ksouda, Kamilia, et al.
Publicado: (2014)

Correlation between Cumulative Methotrexate Dose, Metabolic Syndrome and Hepatic Fibrosis Detected by FibroScan in Rheumatoid Arthritis Patients
por: Lertnawapan, Ratchaya, et al.
Publicado: (2023)

miRNA-24 Gene Sequence, DHFR −829C-T Genotypes, and Methotrexate Response in Mexican Patients with Rheumatoid Arthritis
por: Hernández-Preciado, Martha Rocio, et al.
Publicado: (2019)

Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis
por: Bergstra, Sytske Anne, et al.
Publicado: (2017)

Efficacy and safety of low-dose tacrolimus for active rheumatoid arthritis with an inadequate response to methotrexate
por: Lee, Won-Seok, et al.
Publicado: (2016)

Hepatic failure in a patient with rheumatoid arthritis treated with methotrexate: A case report
por: Miyata, Masayuki, et al.
Publicado: (2023)

Evaluation, Identification, and Management of Acute Methotrexate Toxicity in High-dose Methotrexate Administration in Hematologic Malignancies
por: Feinsilber, Doron, et al.
Publicado: (2018)

Effect of Missed Doses on the Therapeutic Effect of Methotrexate for Rheumatoid Arthritis: A Pharmacokinetic Modeling Study
por: Morrison, Alan, et al.
Publicado: (2021)

Real-World Methotrexate Dose on Clinical Effectiveness and Structural Damage of Certolizumab Pegol With Rheumatoid Arthritis
por: Nozaki, Yuji, et al.
Publicado: (2021)

Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
por: Jeiziner, Chiara, et al.
Publicado: (2022)

Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis
por: Bello, Alfonso E, et al.
Publicado: (2017)

Safety Profile of Methotrexate Therapy in Patients With Rheumatoid Arthritis
por: Mustafa, Syed Hassan, et al.
Publicado: (2022)

Rheumatoid arthritis and Hailey‐Hailey disease treated with methotrexate
por: Mestre, Beatriz, et al.
Publicado: (2022)

Efficacy of etanercept in combination with methotrexate in moderate-to-severe rheumatoid arthritis is not dependent on methotrexate dosage
por: Gallo, G, et al.
Publicado: (2016)

Strategic use of levofolinic acid for methotrexate-induced side effects in juvenile idiopathic arthritis: a prospective observational study
por: Martini, Giorgia, et al.
Publicado: (2023)

Systemic Review and Meta-Analysis of the Clinical Efficacy and Adverse Effects of Zhengqing Fengtongning Combined with Methotrexate in Rheumatoid Arthritis
por: Chen, Xiu-min, et al.
Publicado: (2015)

Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
por: Salliot, C, et al.
Publicado: (2008)

Pharmacogenomics of Methotrexate Membrane Transport Pathway: Can Clinical Response to Methotrexate in Rheumatoid Arthritis Be Predicted?
por: Lima, Aurea, et al.
Publicado: (2015)

Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab
por: Burmester, Gerd R, et al.
Publicado: (2017)

Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?
por: Chen, Hsin-Hua, et al.
Publicado: (2016)

Dose Adjustment of Methotrexate Administered Concomitantly with Golimumab for Rheumatoid Arthritis in Japanese Real-World Clinical Settings
por: Yamairi, Fumiko, et al.
Publicado: (2020)

Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry
por: Pappas, Dimitrios A., et al.
Publicado: (2020)

A dose-dependent beneficial effect of methotrexate on the risk of interstitial lung disease in rheumatoid arthritis patients
por: Kur-Zalewska, Joanna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f3qd82p0bqshn06v29g584b09r